Glaxosmithkline | Betriebsaufwand



Operating Expenses Veränderung Datum
AbbVie USD 9.71B 96M 2025-06
Amgen USD 6.52B 337M 2025-06
AstraZeneca USD 10.95B 1.04B 2025-06
Aurora Cannabis CAD 51.98M 31.53M 2024-12
Bausch Health Companies USD 2.07B 90M 2025-06
Bristol-Myers Squibb USD 8.5B 265M 2025-06
Canopy Growth CAD 98.58M 10.03M 2024-12
Corcept Therapeutics USD 167.76M 13.96M 2025-06
Drreddys Laboratories INR 64.87B 2.26B 2024-12
Eli Lilly USD 8.54B 1.22B 2025-06
GlaxoSmithKline GBP 5.96B 663M 2025-06
Glaxosmithkline GBP 7.42B 408M 2024-12
J&J USD 16.8B 8.54B 2025-06
Merck USD 9.44B 217M 2025-06
Novartis USD 9.97B 1.02B 2025-06
Pacira USD 170.87M 3.93M 2025-06
Perrigo USD 1B 36.2M 2025-06
Pfizer USD 11.62B 1.58B 2025-06
Prestige Brands USD 177.77M 30.32M 2025-06
Roche Holding CHF 11.43B 1.48B 2024-12
Sanofi EUR 9.02B 702M 2025-06
Supernus Pharmaceuticals USD 153.31M 892K 2025-06
Takeda JPY 922.12B 206.21B 2025-06
Teva Pharmaceutical Industries USD 3.28B 95M 2025-06
Zoetis USD 1.44B 35M 2025-06


Glaxosmithkline Betriebsaufwand - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Aug 2025.